Finally, a well deserve breakout- $CUR

I love this stock simply because it offers hope to patients suffering from ALS.  Phase I trial has been successful and it looks like FDA is now offering some flexibility by allowing a public forum to air its concern about the issue involving the Phase II trial.

However, to me, the most important part is the break-out chart:

As you can see, while I have bought $CUR before the breakout happens, I’ve been waiting for it to happen.  And today, price action finally break-out of the downtrend line in a BIG way.

I’m a fortunate man this week, most of my biotech stocks I have bought are in green.

Go Biotech!

My 2 cents.